Literature DB >> 17360782

Is there a microangiopathic antiphospholipid syndrome?

Ronald A Asherson, Sylvia S Pierangeli, Ricard Cervera.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17360782      PMCID： PMC1856041          DOI： 10.1136/ard.2006.067033

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  84 in total

1.  The catastrophic antiphospholipid syndrome--Asherson's syndrome.

Authors:  Jean-Charles Piette; Ricard Cervera; Roger A Levy; Eugeny L Nasonov; Douglas A Triplett; Yehuda Shoenfeld
Journal:  Ann Med Interne (Paris)       Date:  2003-09

2.  A "primary" antiphospholipid syndrome?

Authors:  R A Asherson
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

Review 3.  Disseminated intravascular coagulation.

Authors:  Sjoukje H Slofstra; C Arnold Spek; Hugo ten Cate
Journal:  Hematol J       Date:  2003

Review 4.  Endothelium activation in the anti-phospholipid syndrome.

Authors:  E Raschi; C Testoni; M O Borghi; S Fineschi; P L Meroni
Journal:  Biomed Pharmacother       Date:  2003-09       Impact factor: 6.529

5.  NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies.

Authors:  Sylvie Dunoyer-Geindre; Philippe de Moerloose; Béatrix Galve-de Rochemonteix; Guido Reber; Egbert K O Kruithof
Journal:  Thromb Haemost       Date:  2002-11       Impact factor: 5.249

6.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

Authors:  Guillermina Girardi; Jessica Berman; Patricia Redecha; Lynn Spruce; Joshua M Thurman; Damian Kraus; Travis J Hollmann; Paolo Casali; Michael C Caroll; Rick A Wetsel; John D Lambris; V Michael Holers; Jane E Salmon
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome.

Authors:  R Pauzner; M Dulitzky; H Carp; H Mayan; R Kenett; Z Farfel; A Many
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

8.  Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: successful outcome using plasma exchange therapy.

Authors:  G Roberts; M M Gordon; D Porter; A G Jardine; I W Gibson
Journal:  Lupus       Date:  2003       Impact factor: 2.911

9.  E-Selectin mediates pathogenic effects of antiphospholipid antibodies.

Authors:  R G Espinola; X Liu; M Colden-Stanfield; J Hall; E N Harris; S S Pierangeli
Journal:  J Thromb Haemost       Date:  2003-04       Impact factor: 5.824

10.  Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP): a prospective analysis.

Authors:  Thalia Romani De Wit; Rob Fijnheer; Herm-Jan Brinkman; Sabina Kersting; Ronald J Hene; Jan A van Mourik
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998
View more
  8 in total

1.  The HELLP syndrome, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Claudio Galarza-Maldonado; Jose Sanin-Blair
Journal:  Clin Rheumatol       Date:  2007-10-03       Impact factor: 2.980

Review 2.  The significance and management of thrombocytopenia in antiphospholipid syndrome.

Authors:  Bahar Artim-Esen; Reyhan Diz-Küçükkaya; Murat İnanç
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

3.  Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Authors:  Sangeetha Ramesh; Craig N Morrell; Cristina Tarango; Gail D Thomas; Ivan S Yuhanna; Guillermina Girardi; Joachim Herz; Rolf T Urbanus; Philip G de Groot; Philip E Thorpe; Jane E Salmon; Philip W Shaul; Chieko Mineo
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 4.  Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome.

Authors:  Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

5.  Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: what we still have to learn?

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2012-04-24       Impact factor: 2.631

6.  D-dimer level and the risk for thrombosis in systemic lupus erythematosus.

Authors:  Haifeng Wu; Daniel J Birmingham; Brad Rovin; Kevin V Hackshaw; Nabil Haddad; Douglas Haden; Chack-Yung Yu; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 7.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 8.  The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.